Dr. Sandeep K. Vashist completed his Ph.D. from Central Scientific Instruments Organisation, India in 2006. He was a Scientist at Bristol-Myers Squibb Pharmaceutical Company, Dublin, Ireland (2006-2009) and Team Leader at Diabetes Research Partnership, NUS Nanoscience and Nanotechnology Initiative, Singapore (2009-2012). Presently, Dr. Vashist is the Head of Immunodiagnostics at HSG-IMIT, Germany. He has done many successful technology transfers (>25) to industries and healthcare; published many high impact-factor (IF) manuscripts; filed several patents; and, presented at several highly prestigious conferences and events. He has received many international awards from renowned institutions such as University of Leeds, UK; awarded for scientific research excellence and innovation many times; and, bestowed with invited complimentary membership of Royal Chemical Society, UK. He is the international expert and reviewer for many scientific funding agencies and several high IF journals in the fields of immunodiagnostics, biosensors, point-of-care devices, assay development, analytical chemistry, bioanalytical sciences, electrochemistry, surface plasmon resonance, nanotechnology, and signal enhancement. Dr. Vashist has extensive knowledge in regulatory affairs and guidelines, clinical trials, validation, quality management, and IP management. Besides these, he is Executive Editor of J Basic Appl Sci and J Pharma Bioanal Sci; Editorial Board member of J Nanomed Nanotechol and J Nanomat Mol Nanotech; and expert reviewer for more than 38 high impact factor journals and funding agencies.

Dr. Sandeep K. Vashist's research interests focus on:

• Analytical chemistry
• Immunodiagnostics
• Smartphone-based diagnostics and devices
• Nanotechnology
• Microfluidics
• Biosensors